` CRLBF (Cresco Labs Inc) vs S&P 500 Comparison - Alpha Spread

C
CRLBF
vs
S&P 500

Over the past 12 months, CRLBF has outperformed S&P 500, delivering a return of +32% compared to the S&P 500's +17% growth.

Stocks Performance
CRLBF vs S&P 500

Loading
CRLBF
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CRLBF vs S&P 500

Performance Gap Between CRLBF and GSPC
HIDDEN
Show

Performance By Year
CRLBF vs S&P 500

Loading
CRLBF
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Cresco Labs Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Cresco Labs Inc
Glance View

Market Cap
330.9m USD
Industry
Pharmaceuticals

Cresco Labs Inc. engages in the business of cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. The company is headquartered in Chicago, Illinois and currently employs 3,500 full-time employees. The company went IPO on 2018-12-03. The firm is the wholesaler of branded cannabis products in the United States. Its brands include Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, the Company’s national dispensary brand, is a wellness-focused retailer. The firm operates in and/ or has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, Arizona, New York, Massachusetts, Michigan and Florida.

CRLBF Intrinsic Value
HIDDEN
Show
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett